News - Page 87 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Numinus Expands Ketamine Therapy for Mental Health in Montreal and announces new brand awareness initiatives USA – English USA – English USA – English España – español Latin America – español

Post published:September 23, 2022
Post category:Press Release

Read more about the article Psyence Group Completes Export of Psilocybin Mushrooms to Canada

Psyence Group Completes Export of Psilocybin Mushrooms to Canada

Post published:September 22, 2022
Post category:Press Release

Read more about the article Optimi Health, ATMA Journey Centers To Proceed With Phase I Natural Psilocybin and MDMA Clinical Trial Application to Health Canada

Optimi Health, ATMA Journey Centers To Proceed With Phase I Natural Psilocybin and MDMA Clinical Trial Application to Health Canada

Post published:September 22, 2022
Post category:Press Release

Read more about the article Braxia Scientific Announces Board Appointment

Braxia Scientific Announces Board Appointment

Post published:September 22, 2022
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Announces Receipt of CDN $450K Cash Refund from Australian Research Program

Algernon Pharmaceuticals Announces Receipt of CDN $450K Cash Refund from Australian Research Program

Post published:September 21, 2022
Post category:Press Release

Read more about the article HAVN Life Provides Corporate Update

HAVN Life Provides Corporate Update

Post published:September 21, 2022
Post category:Press Release

Read more about the article MindMed Collaborators Dose First Patient in Phase 1 Investigator-Initiated Trial of MDMA-Like Substances

MindMed Collaborators Dose First Patient in Phase 1 Investigator-Initiated Trial of MDMA-Like Substances

Post published:September 21, 2022
Post category:Press Release

Read more about the article COMPASS Pathways to participate in upcoming Jefferies Innovation in Mental Health Summit

COMPASS Pathways to participate in upcoming Jefferies Innovation in Mental Health Summit

Post published:September 21, 2022
Post category:Press Release

Read more about the article Bexson Biomedical Announces Renowned Scientist, Engineer and Inventor, Robert S. Langer ScD, Joins Its Scientific Advisory Board

Bexson Biomedical Announces Renowned Scientist, Engineer and Inventor, Robert S. Langer ScD, Joins Its Scientific Advisory Board

Post published:September 20, 2022
Post category:Press Release

Read more about the article Psyence Group Receives Phase IIa Clinical Trial Approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA)

Psyence Group Receives Phase IIa Clinical Trial Approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA)

Post published:September 19, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.